Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02655302

Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Chronic obstructive pulmonary disease (COPD) is a worldwide chronic inflammatory disease of the airways linked to environmental exposure. The chronic course of COPD is often interrupted by acute exacerbations which have a major impact on the morbidity and mortality of COPD patients. A bacterial etiology for these exacerbations is common (almost 50%). Moreover, airway bacterial colonization linked to an increased susceptibility is observed in COPD patients. Effective Th17 immune response is needed to develop a good response against bacteria. Thus, this study aims to demonstrate that there is a defective IL-17/ IL-22 response to bacteria in COPD leading to airway bacterial colonization and infection.

Conditions

Interventions

TypeNameDescription
OTHERSample collectingCollect sputum, blood and nasopharyngeal swab during the exacerbation and at steady state 8 to 16 weeks later.
OTHERLung function measureMeasure lung function and follow it during 4 years

Timeline

Start date
2018-07-04
Primary completion
2028-07-01
Completion
2028-07-01
First posted
2016-01-14
Last updated
2023-01-27

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02655302. Inclusion in this directory is not an endorsement.